The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post–Liver Transplantation Using Transient Elastography With Controlled Attenuation Parameter

2020 ◽  
Author(s):  
Maneerat Chayanupatkul ◽  
Divya B. Dasani ◽  
Kristian Sogaard ◽  
Thomas D. Schiano
Keyword(s):  
Liver Transplantation ◽  
Transient Elastography ◽  
Controlled Attenuation Parameter ◽  
Liver Allograft ◽  
Attenuation Parameter

Prognostic Value of Controlled Attenuation Parameter by Transient Elastography

2017 ◽  
Vol 112 (12) ◽  
pp. 1812-1823 ◽  
Author(s):  
Ken Liu ◽  
Vincent Wai-Sun Wong ◽  
Keith Lau ◽  
Sienna Du Liu ◽  
Yee-Kit Tse ◽  
...  
Keyword(s):  
Prognostic Value ◽  
Transient Elastography ◽  
Controlled Attenuation Parameter ◽  
Attenuation Parameter

scholarly journals Screening for non‐alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter‐transient elastography

JGH Open ◽  
2020 ◽  
Vol 4 (2) ◽  
pp. 245-250
Author(s):  
Nicha Teeratorn ◽  
Panida Piyachaturawat ◽  
Kessarin Thanapirom ◽  
Roongruedee Chaiteerakij ◽  
Kanokwan Sonsiri ◽  
...  
Keyword(s):  
Cohort Study ◽  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Transient Elastography ◽  
Community Setting ◽  
Controlled Attenuation Parameter ◽  
Alcoholic Fatty Liver ◽  
Attenuation Parameter ◽  
Alcoholic Fatty Liver Disease

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

2012 ◽  
Vol 32 (6) ◽  
pp. 911-918 ◽  
Author(s):  
Victor Lédinghen ◽  
Julien Vergniol ◽  
Juliette Foucher ◽  
Wassil Merrouche ◽  
Brigitte Bail
Keyword(s):  
Transient Elastography ◽  
Liver Steatosis ◽  
Controlled Attenuation Parameter ◽  
Non Invasive ◽  
Attenuation Parameter

Potential impact of screening for fatty liver disease by transient elastography with liver stiffness and controlled attenuation parameter measurements: a pilot study

2017 ◽  
Vol 55 (08) ◽  
pp. 754-760
Author(s):  
Moritz Peiseler ◽  
Anna Creutzfeldt ◽  
Insa Cassens ◽  
Claudia Glaubke ◽  
Claudia Kroll ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Pilot Study ◽  
Liver Diseases ◽  
Transient Elastography ◽  
Liver Stiffness ◽  
Chronic Liver ◽  
Chronic Liver Diseases ◽  
Normal Range ◽  
Controlled Attenuation Parameter ◽  
Attenuation Parameter

Abstract Background The prevalence of chronic liver diseases is high in developed countries, and the leading causes are amenable to prevention. The German Lebertag is to increase awareness of the burden of chronic liver diseases in the general public. We performed a pilot study using transient elastography with liver stiffness measurement (LSM) and the controlled attenuation parameter (CAP) as a screening tool for previously unrecognized liver diseases. Patients and methods LSM and CAP was performed in 60 individuals, and participants filled in a questionnaire reporting basic characteristics and past medical history. Results Median LSM and CAP values were within the normal range. Participants with self-reported diabetes mellitus had significantly elevated LSM (p = 0.02) and CAP values (p = 0.002). Participants with a BMI > 30 kg/m2 or dyslipidemia had significantly elevated CAP values (p = 0.007 and p = 0.01, respectively) with normal LSM values. Overall, 35 % of participants had elevated CAP values, indicating a high prevalence of hepatic steatosis. Discussion In a German pilot study, diabetes mellitus was a key risk factor for increased LSM and CAP values. Prevalence of steatosis was high and comparable to other Western countries. Transient elastography is a valuable tool to identify patients with increased risk for metabolic liver diseases. In people without risk factors, LSM and CAP values were within the normal range, indicating that screening for chronic liver injury was not warranted.

Sign in / Sign up

Export Citation Format

Share Document